In the past week, OABI stock has gone up by 0.28%, with a monthly decline of -13.98% and a quarterly plunge of -15.60%. The volatility ratio for the week is 3.93%, and the volatility levels for the last 30 days are 4.43% for OmniAb Inc. The simple moving average for the past 20 days is -6.15% for OABI’s stock, with a -17.90% simple moving average for the past 200 days.
Is It Worth Investing in OmniAb Inc (NASDAQ: OABI) Right Now?
The 36-month beta value for OABI is at -0.10. Analysts have varying views on the stock, with 6 analysts rating it as a “buy,” 2 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for OABI is 97.86M, and currently, shorts hold a 7.28% of that float. The average trading volume for OABI on December 27, 2024 was 412.64K shares.
OABI) stock’s latest price update
The stock price of OmniAb Inc (NASDAQ: OABI) has jumped by 1.13 compared to previous close of 3.53. Despite this, the company has seen a gain of 0.28% in its stock price over the last five trading days. businesswire.com reported 2024-12-16 that EMERYVILLE, Calif.–(BUSINESS WIRE)–OmniAb, Inc. (NASDAQ: OABI) today announced that two presentations featuring the Company’s technologies were delivered at the 2024 Antibody Engineering & Therapeutics Conference (AETC) underway in San Diego. In a presentation titled “Building Multispecifics from in vivo Derived Antibody Domains and Alternative Scaffolds,” Yasmina Abdiche, Ph.D., Vice President of Exploratory Research, provided an overview of building multispecifics ranging from tradition.
Analysts’ Opinion of OABI
Many brokerage firms have already submitted their reports for OABI stocks, with RBC Capital Mkts repeating the rating for OABI by listing it as a “Outperform.” The predicted price for OABI in the upcoming period, according to RBC Capital Mkts is $6 based on the research report published on November 29, 2023 of the previous year 2023.
The Benchmark Company, on the other hand, stated in their research note that they expect to see OABI reach a price target of $8. The rating they have provided for OABI stocks is “Buy” according to the report published on April 21st, 2023.
Craig Hallum gave a rating of “Buy” to OABI, setting the target price at $10 in the report published on April 13th of the previous year.
OABI Trading at -10.17% from the 50-Day Moving Average
After a stumble in the market that brought OABI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -46.84% of loss for the given period.
Volatility was left at 4.43%, however, over the last 30 days, the volatility rate increased by 3.93%, as shares sank -5.56% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.62% lower at present.
During the last 5 trading sessions, OABI rose by +0.28%, which changed the moving average for the period of 200-days by -33.40% in comparison to the 20-day moving average, which settled at $3.80. In addition, OmniAb Inc saw -42.14% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OABI starting from Berkman Charles S, who sale 8,022 shares at the price of $4.13 back on Dec 09 ’24. After this action, Berkman Charles S now owns 323,385 shares of OmniAb Inc, valued at $33,131 using the latest closing price.
FOEHR MATTHEW W, the President and CEO of OmniAb Inc, sale 13,634 shares at $4.13 during a trade that took place back on Dec 09 ’24, which means that FOEHR MATTHEW W is holding 3,714,447 shares at $56,308 based on the most recent closing price.
Stock Fundamentals for OABI
Current profitability levels for the company are sitting at:
- -3.91 for the present operating margin
- 0.22 for the gross margin
The net margin for OmniAb Inc stands at -3.09. The total capital return value is set at -0.25. Equity return is now at value -20.45, with -17.43 for asset returns.
Based on OmniAb Inc (OABI), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -239.7. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -60.26.
Currently, EBITDA for the company is -49.73 million with net debt to EBITDA at 0.05. When we switch over and look at the enterprise to sales, we see a ratio of 21.0. The receivables turnover for the company is 5.84for trailing twelve months and the total asset turnover is 0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.62.
Conclusion
In conclusion, OmniAb Inc (OABI) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
